APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients

Kao, JH; Jeng, WJ; Ning, Q; Su, TH; Tseng, TC; Ueno, Y; Yuen, MF

Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Kao, JH (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.

HEPATOLOGY INTERNATIONAL, 2021; 15 (4): 833

Abstract

Chronic hepatitis B virus (HBV) infection is currently incurable. Long-term treatment with potent and safe nucleos(t)ide analogs (NAs) can reduce hepa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索